Theravance Share Price
NASDAQ: TBPH | HealthcareTheravance Stock Performance
Theravance Share Price Chart
Theravance Quarterly Profit & Loss
All figures in USD
Theravance Annual Profit & Loss
All figures in USD
Theravance Balance Sheet
All figures in USD Million
Theravance Cash Flow
All figures in USD Million
About Theravance
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.
Theravance Historical Returns
| Month | Open | Close | Change % |
|---|